Arrowhead pharmaceuticals, inc. (ARWR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
REVENUE

23,528

29,454

43,292

42,696

48,148

34,657

11,255

727

650

3,509

8,713

9,342

8,985

4,365

31

39

43

43

43

123

43

170

43

43

43

43

43

43

43

159

43

47

31

23

0

0

0

296

-

OPERATING EXPENSES
Research and development

29,443

23,373

23,386

19,291

20,798

17,572

15,993

12,052

12,002

12,919

18,802

11,136

11,438

9,527

32,334

9,423

10,020

10,338

10,391

7,490

11,640

17,744

8,396

6,392

5,216

3,133

3,247

1,756

2,125

1,576

2,044

1,219

1,358

769

509

365

140

2,261

123

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Salaries and payroll-related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

4,276

-

4,113

4,248

3,919

6,291

3,570

3,541

3,150

5,195

2,454

3,097

2,081

1,661

1,651

1,725

1,629

1,422

1,654

2,017

1,320

320

354

425

307

81

General and administrative expenses

16,325

10,934

10,268

4,809

5,338

6,139

6,430

4,594

3,681

4,403

8,047

3,919

3,677

1,854

15,549

2,275

3,818

1,951

2,318

1,829

1,696

2,086

2,050

1,582

1,347

913

891

899

779

917

1,104

3,137

930

1,266

1,711

637

815

631

736

Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

2,424

-

2,750

2,416

2,380

3,526

2,486

2,205

2,014

1,937

2,038

1,198

521

421

363

355

395

404

415

169

251

297

346

362

370

390

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

1,185

-

818

803

794

855

741

449

290

270

276

395

403

398

454

448

449

447

423

423

454

-

66

67

-

-

Contingent consideration - fair value adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Impairment expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,308

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

60

TOTAL OPERATING EXPENSES

45,769

34,308

33,654

24,100

26,137

23,711

22,424

16,647

15,684

17,323

18,964

15,056

15,115

19,267

21,826

19,381

21,308

19,385

25,276

16,117

29,676

25,286

22,398

12,743

11,256

7,053

8,042

6,433

5,434

4,969

5,422

6,850

4,900

4,062

2,912

1,770

1,811

3,631

1,391

OPERATING INCOME (LOSS)

-22,240

-4,853

9,638

18,595

22,010

10,946

-11,169

-15,919

-15,034

-13,813

-10,250

-5,714

-6,129

-14,901

-21,795

-19,341

-21,264

-19,341

-25,232

-15,993

-29,632

-25,115

-22,354

-12,700

-11,212

-7,009

-7,999

-6,389

-5,390

-4,810

-5,378

-6,802

-4,868

-4,039

-2,912

-1,770

-1,811

-3,335

-1,391

OTHER INCOME (EXPENSE)
Equity in income (loss) of unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

78

-9

-138

-260

-159

-157

-63

-34

-34

-64

-106

-66

-70

-74

48

-66

Impairment on investment in unconsolidated affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,455

-

-

-

-

-

-

-

Gain on purchase of Roche Madison

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

1,576

-

-

-

-

-

Gain (loss) on sale of fixed asset, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

45

-26

0

0

-5

-53

0

-39

-54

18

-

-876

-33

-

-

-

-

-

-

Interest income (expense), net

2,404

2,179

2,240

1,739

1,886

1,091

402

313

168

163

149

131

108

25

52

34

79

100

131

162

198

237

259

226

119

40

-29

-48

-27

7

8

14

5

7

15

20

35

15

-9

Realized and unrealized gain (loss) in marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-58

-

-498

359

-

-

Change in value of derivatives

-

-

-

-

-

-

0

0

-18

450

-629

63

-27

1,483

-534

-113

369

-23

422

-104

168

2,382

-321

758

-2,951

-3,519

-5,516

200

-29

44

160

915

-622

-66

-110

373

404

465

1,552

Gain on sale of stock in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

0

0

5

1,306

-

-

-

-

-65

0

536

-53

0

10

76

-5

0

259

-1,279

22

-

-

-

-

-

-

-

-

-

TOTAL OTHER INCOME (EXPENSE)

2,404

2,179

2,240

1,739

1,886

1,091

410

313

149

614

-479

194

87

2,815

-424

-79

448

76

489

57

948

2,539

-70

1,073

-2,770

-3,676

-5,805

212

-1,549

29

-222

-1,436

-714

1,352

-33

-174

724

529

1,475

INCOME (LOSS) BEFORE INCOME TAXES

-19,835

-2,673

11,878

20,335

23,896

12,037

-10,758

-15,606

-14,884

-13,198

-10,729

-5,519

-6,042

-12,086

-22,219

-19,420

-20,815

-19,264

-24,743

-15,936

-28,683

-22,575

-22,425

-11,626

-13,982

-10,685

-13,805

-6,177

-6,939

-4,780

-5,600

-8,239

-5,583

-2,686

-2,946

-1,944

-1,087

-2,806

84

Provision for income taxes

-

-

-

0

-

-

2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

LOSS FROM CONTINUING OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,805

-6,177

-6,939

-4,780

-5,600

-8,239

-5,583

-2,686

-2,946

-1,944

-1,087

-2,806

84

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-0

-

0

-0

-0

-0

-68

-132

1,574

-768

Gain on disposal of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,919

-

-

NET LOSS FROM DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-0

-0

-0

0

-0

-0

-0

-68

3,786

1,574

-768

NET LOSS

-

-

-

-

-

-

-

-

-

-

-

-5,519

-6,042

-12,086

-22,221

-19,420

-20,815

-19,264

-24,745

-15,936

-28,683

-22,575

-22,430

-11,626

-13,982

-10,685

-13,805

-6,177

-6,940

-4,780

-5,600

-8,239

-5,584

-2,686

-2,946

-2,013

2,699

-1,231

-683

Net loss attributable to non-controlling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

2

-40

-57

-112

-98

-182

-166

-287

-247

-248

-201

-170

-193

-205

206

-312

NET INCOME (LOSS)

-19,835

-2,673

11,704

20,335

23,896

12,037

-10,761

-15,606

-14,884

-13,198

-

-

-

-

-

-

-

-

-

-15,936

-28,683

-22,575

-22,430

-11,628

-13,942

-10,628

-13,692

-6,079

-6,757

-4,614

-5,313

-7,991

-5,335

-2,485

-2,776

-1,819

2,905

-1,437

-371

NET LOSS PER SHARE - BASIC & DILUTED

-

-

-

-

-

-

-

-

-

-

-

-0.07

-0.08

-0.17

-0.35

-0.32

-0.35

-0.32

-0.41

-0.27

-0.51

-0.41

-0.44

-0.22

-0.31

-0.28

-0.33

-0.23

-0.41

-0.33

-

-0.71

-

-

-

-

-

-

-

Loss from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.50

-0.25

-

-0.24

-0.13

-

-

Income from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

-

-0.01

0.53

-

-0.01

NET INCOME (LOSS) PER SHARE - BASIC

-0.20

-0.03

0.13

0.21

0.25

0.13

-0.11

-0.18

-0.18

-0.18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.50

-0.25

-

-0.25

0.40

-

-0.01

Income (loss) from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.24

-0.11

-

-

Income (loss) from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.48

-

-0.01

NET INCOME (LOSS) PER SHARE - DILUTED

-0.20

-0.03

0.11

0.21

0.24

0.13

-0.11

-0.18

-0.18

-0.18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.25

0.37

-

-0.01

Weighted average shares outstanding - basic

101,653

97,090

95,252

94,935

94,155

91,091

88,004

87,634

84,083

74,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,182

7,180

-

64,579

Weighted average shares outstanding - diluted

101,653

97,090

101,873

98,884

98,082

95,590

88,004

87,634

84,083

74,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,182

7,891

-

64,579

Loss from continuing operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.42

-

Income from discontinued operations attributable to Arrowhead common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.22

-

Net loss attributable to Arrowhead shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.20

-

Weighted average shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

74,772

74,629

71,444

64,908

59,966

59,779

59,548

59,528

59,492

55,719

54,692

53,736

51,931

44,321

37,741

39,299

26,134

16,461

14,113

12,495

11,238

10,663

10,121

-

-

-

7,177

-

OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:
Foreign currency translation adjustments

-433

196

-288

-31

-28

-22

-18

-28

1

-9

51

12

154

-192

38

-90

150

45

-

-1

-63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE INCOME (LOSS)

-20,269

-2,477

11,416

20,304

23,868

12,015

-10,779

-15,634

-14,882

-13,208

-10,680

-5,507

-5,888

-12,278

-22,183

-19,511

-20,665

-19,218

-24,816

-15,938

-28,747

-22,575

-

-11,628

-13,942

-

-

-

-

-

-

-

-

-

-

-

-

-

-